Hologic's 15min chart triggers Bollinger Bands Narrowing, KDJ Death Cross detected.

Thursday, Aug 21, 2025 2:54 pm ET2min read

Hologic's 15-minute chart has exhibited Bollinger Bands Narrowing, and a KDJ Death Cross at 08/21/2025 14:45. This indicates a decrease in the magnitude of stock price fluctuations, with momentum shifting towards the downside and potentially leading to further decreases.

Hologic's 15-minute chart has exhibited significant technical indicators that suggest a potential downward trend in the stock price. The Bollinger Bands have narrowed, and a KDJ Death Cross occurred on August 21, 2025, at 14:45. These indicators suggest a decrease in the magnitude of stock price fluctuations and a shift in momentum towards the downside, potentially leading to further decreases in the stock price [1].

The Bollinger Bands Narrowing is a technical analysis tool that suggests a decrease in the range of stock price fluctuations. When the bands narrow, it often precedes a change in trend, signaling a potential reversal in stock price movement. The KDJ Death Cross, formed when the K line crosses below the D line on the chart, typically signifies a bearish trend. This suggests that the short-term average price is falling below the long-term average price, indicating a potential decline in the stock price [1].

These developments follow a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks, including ASGN and Cushing NextGen [1]. While these technical indicators provide valuable insights into potential stock price movements, investors should consider these signals in conjunction with fundamental analysis and broader market conditions.

In addition to the technical indicators, several analyst ratings and price targets have been updated recently, offering valuable insights into the potential performance of various stocks. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts [1].

Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].

References:
[1] https://www.ainvest.com/news/forrester-research-15min-chart-triggers-bollinger-bands-narrowing-kdj-death-cross-2508/

Comments



Add a public comment...
No comments

No comments yet